NCT05490511View on ClinicalTrials.gov

Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
CBDTransplant ComplicationKidney Disease, Chronic
Interventions
DRUG

Tacrolimus single dose

5 mg once

DRUG

Epidiolex single dose

Epidiolex 5 mg/kg

DRUG

Epidiolex steady-state and tacrolimus single dose

Epidiolex at up to 5 mg/kg twice daily (for 14 days) and tacrolimus 5 mg once on day 12 of period

Trial Locations (1)

46202

IU Health University Hospital, Indianapolis

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Indiana University

OTHER